Your browser doesn't support javascript.
loading
Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients.
Graham, Richard T; Bell, Erica H; Webb, Amy; Zhao, Yue; Timmers, Cynthia; Fleming, Jessica L; Sells, Blake E; Robison, Nathan J; Palmer, Joshua D; Finlay, Jonathan L; Chakravarti, Arnab.
Afiliação
  • Graham RT; Division of Neuro-Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Bell EH; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
  • Webb A; Center for Biostatistics, The Ohio State University.
  • Zhao Y; Center for Biostatistics, The Ohio State University.
  • Timmers C; The Ohio State University Comprehensive Cancer Center.
  • Fleming JL; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
  • Sells BE; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
  • Robison NJ; Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, CA.
  • Palmer JD; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
  • Finlay JL; Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH.
  • Chakravarti A; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
J Pediatr Hematol Oncol ; 43(8): e1201-e1204, 2021 11 01.
Article em En | MEDLINE | ID: mdl-33235140
ABSTRACT
Gliosarcoma is rare among pediatric patients and among individuals with Neurofibromatosis Type 1 (NF1). Here we compare 2 pediatric gliosarcoma patients, one of whom has NF1. We performed whole-exome sequencing, methylation, and copy number analysis on tumor and blood for both patients. Whole-exome sequencing showed higher mutational burden in the tumor of the patient without NF1. Copy number analysis showed differences in chromosomal losses/gains between the tumors. Neither tumor showed O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation. The NF1 patient survived without progression while the other expired. This is the first reported case of gliosarcoma in a child with NF1.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metilases de Modificação do DNA / Neurofibromatose 1 / Gliossarcoma / Proteínas Supressoras de Tumor / Enzimas Reparadoras do DNA / Exoma / Sequenciamento do Exoma / Mutação Tipo de estudo: Prognostic_studies Limite: Child / Female / Humans / Male Idioma: En Revista: J Pediatr Hematol Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metilases de Modificação do DNA / Neurofibromatose 1 / Gliossarcoma / Proteínas Supressoras de Tumor / Enzimas Reparadoras do DNA / Exoma / Sequenciamento do Exoma / Mutação Tipo de estudo: Prognostic_studies Limite: Child / Female / Humans / Male Idioma: En Revista: J Pediatr Hematol Oncol Ano de publicação: 2021 Tipo de documento: Article